{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":37,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":37,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"4468135ef0ab","filters":{"venue":"Current Cancer Drug Targets"}},"results":[{"id":"W2032167680","doi":"10.2174/15680096113139990076","title":"P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives","year":2013,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"P-glycoprotein; Multiple drug resistance; Efflux; Pharmacology; Drug resistance; Cancer cell; Chemotherapy; Drug; Cancer; Medicine; Cancer research; Biology; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04291776460267629,"gpt":0.3592649070629227,"spread":0.3163471424602464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003300782,0.001073445,0.002594238,0.0004844235,0.0002143454,0.00007816291,0.0001971774,0.0003317026,0.0001326865],"category_scores_gemma":[0.00001805643,0.0008364713,0.0006359047,0.0005398801,0.0001747897,0.0002458813,0.00005633841,0.001316598,0.000006231051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001456153,"about_ca_system_score_gemma":0.00127585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002331946,"about_ca_topic_score_gemma":0.000490595,"domain_scores_codex":[0.9956986,0.000149172,0.00101104,0.001504667,0.0005757886,0.001060688],"domain_scores_gemma":[0.9981342,0.00007405932,0.0006490892,0.0005087486,0.000254688,0.0003792426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001961514,0.0005241464,0.00007398701,0.07531779,0.0002076148,0.000006803853,0.003468987,0.0000014254,0.000008393488,0.001575511,0.0007363979,0.9178828],"study_design_scores_gemma":[0.002367626,0.00003623338,0.0000980665,0.03340458,0.001103212,0.000003747056,0.00094494,0.00004294843,0.00003661352,0.0004734914,0.9606006,0.000887962],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004330616,0.9878827,0.0003227895,0.0002132535,0.001991634,0.008233127,0.0006910415,0.0001051528,0.0001272418],"genre_scores_gemma":[0.0003522086,0.9844238,0.001244468,0.00002668095,0.001993706,0.01048346,0.00072086,0.0001889691,0.0005658105],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9598642,"threshold_uncertainty_score":0.9994086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010349266","doi":"10.2174/156800907780058862","title":"From ONYX-015 to Armed Vaccinia Viruses: The Education and Evolution of Oncolytic Virus Development","year":2007,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Vaccinia; Oncolytic virus; Virology; Virus; Biology; Medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05896900290161484,"gpt":0.4196466402453708,"spread":0.360677637343756,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005121205,0.0004056043,0.000651931,0.000178966,0.0001161601,0.00002806314,0.0005223315,0.0001885853,0.00006662768],"category_scores_gemma":[0.00006572388,0.000306511,0.0001684615,0.0002979912,0.00006945142,0.000004988769,0.0002593395,0.0002966283,0.00003557585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005246993,"about_ca_system_score_gemma":0.003975916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003074473,"about_ca_topic_score_gemma":0.001478552,"domain_scores_codex":[0.9977658,0.0002172982,0.0006162301,0.0006551351,0.0003600098,0.0003855134],"domain_scores_gemma":[0.9986203,0.00005712314,0.0003336092,0.0005880612,0.0002047945,0.0001960919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002213196,0.0001670802,0.00003966067,0.001316959,0.0001949429,2.50916e-7,0.0003260462,0.000003385939,0.001364115,0.000002370978,0.006821061,0.9895428],"study_design_scores_gemma":[0.0002202814,0.0001554863,0.00009439012,0.002274034,0.0001492355,0.000001114912,0.00005412146,0.000001579941,0.009330782,0.00001620593,0.9873633,0.0003394419],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02239441,0.9748068,0.00009111438,0.000035075,0.001148608,0.001282671,0.0001904336,0.000009477414,0.00004141817],"genre_scores_gemma":[0.001664652,0.9958286,0.0001259584,0.0000868225,0.001052536,0.0006565702,0.0003754588,0.0000615614,0.0001478515],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9892034,"threshold_uncertainty_score":0.9999387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984087096","doi":"10.2174/156800907780058853","title":"Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus","year":2007,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Georgetown University; University of Pennsylvania","keywords":"Oncolytic virus; Medicine; Tolerability; Adverse effect; Desensitization (medicine); Regimen; Dosing; Toxicity; Pharmacology; Bolus (digestion); Phases of clinical research; Newcastle disease; Clinical trial; Internal medicine; Oncology; Virus; Cancer; Immunology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.2442977759870614,"gpt":0.5522660217318367,"spread":0.3079682457447753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006475097,0.0004914505,0.001014766,0.000139973,0.0001058594,0.00003571557,0.0006220295,0.0002595188,0.0001403621],"category_scores_gemma":[0.0001063282,0.000461655,0.0005180508,0.000248331,0.0003163074,0.00001299287,0.0001464459,0.0004367099,0.00001008213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001675841,"about_ca_system_score_gemma":0.003438009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003264304,"about_ca_topic_score_gemma":0.0001823335,"domain_scores_codex":[0.996576,0.0004170056,0.001098692,0.0009213699,0.0004418219,0.0005451255],"domain_scores_gemma":[0.9976715,0.00003862585,0.0006067949,0.0008902812,0.000211005,0.0005817353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001482206,0.001610064,0.00001345684,0.002372929,0.0001054319,0.00002138391,0.00007237735,0.00001147003,0.0009847247,0.000001787992,0.0002637491,0.9930604],"study_design_scores_gemma":[0.001101696,0.002274468,0.00000485078,0.001995405,0.0003434918,0.000008330154,0.00002187041,0.0001318725,0.006093967,0.000006094606,0.9874169,0.0006010407],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06303287,0.9339581,0.0002952543,0.000005363162,0.00117851,0.0009301921,0.0005712741,0.00001403447,0.00001448107],"genre_scores_gemma":[0.006695572,0.9902052,0.0001011773,0.00002763053,0.001654764,0.0001617865,0.001012175,0.0000875807,0.00005411549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9924594,"threshold_uncertainty_score":0.9997835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996963479","doi":"10.2174/156800912799277511","title":"The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases","year":2012,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Canada Research Chairs","keywords":"Medicine; Blood–brain barrier; Chemotherapy; Brain tumor; Brain metastasis; Radiation therapy; Oncology; Brain cancer; Cancer; Internal medicine; Pathology; Central nervous system; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.05824059173052305,"gpt":0.3778907565616442,"spread":0.3196501648311212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006325328,0.0007457798,0.001987355,0.0002187082,0.0001774538,0.00004511555,0.0004408171,0.0001018856,0.0001202571],"category_scores_gemma":[0.0001984195,0.0003337475,0.0008749513,0.000580753,0.0001745079,0.00009158134,0.00005740396,0.0003288002,0.00004416336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004207122,"about_ca_system_score_gemma":0.0006466778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002429834,"about_ca_topic_score_gemma":0.0002902223,"domain_scores_codex":[0.9965941,0.0005867886,0.0009971772,0.000534091,0.0005903959,0.000697394],"domain_scores_gemma":[0.9965249,0.00159712,0.000636005,0.0008933996,0.0001229612,0.0002255704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000019026,0.002122859,0.001323381,0.005029379,0.0008338817,0.00007823426,0.001053792,0.000003543664,0.00000179965,0.0002748329,0.003928063,0.9853312],"study_design_scores_gemma":[0.001273868,0.0002074349,0.000616712,0.008395699,0.004390321,0.00003915181,0.00006249934,0.000001381769,0.0001286855,0.00001267642,0.9845974,0.0002741209],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004849294,0.9893093,1.230655e-7,0.001222351,0.0006886495,0.003139707,0.0007040794,0.00002222321,0.00006434081],"genre_scores_gemma":[0.003499228,0.9915388,0.000008320391,0.0001085128,0.0003881631,0.004026061,0.0002333114,0.00005790186,0.0001396895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9850571,"threshold_uncertainty_score":0.9999114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071527358","doi":"10.2174/156800906777441753","title":"Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines","year":2006,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple drug resistance; Inflammation; Proinflammatory cytokine; P-glycoprotein; Biology; Drug resistance; ATP-binding cassette transporter; Efflux; Cancer; Mechanism (biology); Cancer research; Immunology; Pharmacology; Transporter; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02796013929946068,"gpt":0.3285002009923362,"spread":0.3005400616928756,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002917208,0.0007805781,0.002584768,0.0002861902,0.0001034622,0.00001614155,0.0003101277,0.000305451,0.0001547522],"category_scores_gemma":[0.00001881137,0.000615196,0.000856999,0.000452666,0.0001743514,0.0001180427,0.00003622454,0.0005878141,0.0000223073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004048545,"about_ca_system_score_gemma":0.0007891852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003376313,"about_ca_topic_score_gemma":0.0001736852,"domain_scores_codex":[0.9962775,0.00009530692,0.001466913,0.0008302628,0.0007900388,0.0005400205],"domain_scores_gemma":[0.9975774,0.00005417958,0.001165962,0.0007168052,0.0002887476,0.0001968508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001230807,0.0003563602,0.0001833866,0.1809367,0.000300991,0.00001915291,0.0001370602,0.000003759183,0.0001269646,0.0003033793,0.1439376,0.6735716],"study_design_scores_gemma":[0.0007229967,0.00001096601,0.00009577308,0.04662219,0.001467807,0.000002413605,0.000005063429,0.000006748683,0.0006620236,0.00009076802,0.9497757,0.0005375458],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005498215,0.993718,0.0001443731,0.00005757212,0.002077813,0.002147546,0.0008362751,0.0001410387,0.0008224091],"genre_scores_gemma":[0.0001178634,0.9826791,0.0003159562,0.000008551454,0.0007665685,0.0005643956,0.002321956,0.0001527337,0.01307285],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8058381,"threshold_uncertainty_score":0.9996299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052792754","doi":"10.2174/1568009043332989","title":"Novel Approaches for Targeted Cancer Therapy","year":2004,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research","keywords":"Cancer; Cancer therapy; Targeted therapy; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1871171494037662,"gpt":0.4140247516751773,"spread":0.2269076022714111,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002421151,0.001471215,0.00376388,0.0003927387,0.0002274939,0.00005198357,0.0005882201,0.0003938875,0.0004644931],"category_scores_gemma":[0.00004139894,0.001137911,0.001580975,0.0006676894,0.0002669716,0.0002023417,0.0001040583,0.001059976,0.00003031053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002479574,"about_ca_system_score_gemma":0.004196882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001643389,"about_ca_topic_score_gemma":0.00004761525,"domain_scores_codex":[0.9953982,0.00006285639,0.001128991,0.00155639,0.0006344852,0.001219031],"domain_scores_gemma":[0.9971887,0.0001421665,0.0009615392,0.0009353312,0.0003262885,0.0004459076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002204282,0.0004695455,0.000009277798,0.04484332,0.001194346,0.000002744078,0.0003501929,0.00006383635,0.00001080455,0.0001581926,0.00154252,0.9511348],"study_design_scores_gemma":[0.004118599,0.0000721308,0.00001419535,0.04086665,0.001473826,0.00002931584,0.0000255461,0.00001878041,0.0001100213,0.0001677132,0.9519897,0.001113553],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004326785,0.9823189,0.002930788,0.0004048204,0.005124669,0.00627876,0.002570814,0.0003052416,0.00006172036],"genre_scores_gemma":[0.00001161411,0.9761196,0.002163987,0.0001558584,0.003652524,0.01523782,0.001281201,0.0004604305,0.0009169336],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9504471,"threshold_uncertainty_score":0.9998037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117191309","doi":"10.2174/156800911794519743","title":"Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention","year":2011,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Proteasome; Prodrug; Pharmacology; Bioavailability; Chemistry; Cancer research; Cancer cell; Apoptosis; Proteasome inhibitor; Cancer; Biochemistry; Biology; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05090194228805152,"gpt":0.3776791703544945,"spread":0.326777228066443,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003769744,0.000737779,0.001959056,0.0004417336,0.00006970335,0.0000289735,0.0003130351,0.000358845,0.0004271397],"category_scores_gemma":[0.00006858827,0.0006098318,0.0006421292,0.0006069416,0.00007148582,0.0001854198,0.0001565318,0.001018337,0.0005102182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008840252,"about_ca_system_score_gemma":0.0009009183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001492415,"about_ca_topic_score_gemma":0.00008226107,"domain_scores_codex":[0.9968197,0.0001761396,0.001006127,0.0009354702,0.0003739798,0.0006885675],"domain_scores_gemma":[0.9980801,0.00004021708,0.0007005382,0.0007592205,0.00009950886,0.0003204342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002237627,0.000330399,0.0001699548,0.03134526,0.00009763858,0.000007246493,0.0003143346,5.04151e-8,0.00001164894,0.0001314076,0.003721131,0.9638485],"study_design_scores_gemma":[0.0007656394,0.0000729649,0.0004392538,0.04881611,0.0007259494,0.00002997436,0.000009410685,0.000002266421,0.00008660809,0.0002520487,0.9482405,0.000559241],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004943564,0.9915314,0.000007178965,0.0001580548,0.001634585,0.005366699,0.00007824478,0.0001452573,0.000584243],"genre_scores_gemma":[0.0005514112,0.9916366,0.00004708338,0.000033716,0.001866645,0.004072333,0.0005352271,0.0001420403,0.001114979],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9632893,"threshold_uncertainty_score":0.9996353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032199025","doi":"10.2174/1568009023333926","title":"Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy","year":2002,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Receptor; Epidermal growth factor receptor; Epidermal growth factor; Cancer research; Extracellular; Biology; Tyrosine kinase; Epitope; Cancer; Receptor tyrosine kinase; Cancer cell; Mutant; Growth factor receptor; Mutation; Growth factor receptor inhibitor; Antibody; Cell biology; Immunology; Biochemistry; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1673419595737975,"gpt":0.4593383807002334,"spread":0.2919964211264359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006487587,0.001786817,0.004808611,0.0007336297,0.0003696609,0.0001220073,0.001111101,0.0006787755,0.01517432],"category_scores_gemma":[0.0004652197,0.001387536,0.002107522,0.001020791,0.00034278,0.0002257055,0.0002382863,0.002377512,0.0005379965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003578826,"about_ca_system_score_gemma":0.004642397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000868723,"about_ca_topic_score_gemma":0.0001196225,"domain_scores_codex":[0.9914201,0.0004557805,0.001853753,0.002179975,0.001738193,0.002352239],"domain_scores_gemma":[0.9950316,0.0005784906,0.000974234,0.001233217,0.0009497646,0.001232713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001157892,0.0003179314,0.0001395552,0.03265094,0.0007627598,0.00004061937,0.0004412232,7.320617e-7,0.00000496963,0.00003231419,0.1675847,0.7979085],"study_design_scores_gemma":[0.001950321,0.0002317518,0.00001492101,0.02664339,0.0007829056,0.00003705114,0.00001823144,0.00002928825,0.0003478258,0.00006257142,0.9685433,0.001338427],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004072738,0.9725307,0.00003859626,0.001387797,0.01368873,0.008563158,0.002945218,0.0002805855,0.0005245226],"genre_scores_gemma":[0.00003446104,0.9745407,0.0001473595,0.0003508656,0.00643283,0.01256539,0.0007473466,0.0005821708,0.00459884],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8009586,"threshold_uncertainty_score":0.9999241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988669425","doi":"10.2174/156800912802429337","title":"Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma","year":2012,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"CD44; Integrin; Extracellular matrix; Cell biology; Cell adhesion molecule; Cell adhesion; Fibronectin; Chemistry; Laminin; Adhesion; Cancer research; Biology; Cell; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1171070461575847,"gpt":0.4100367581634505,"spread":0.2929297120058657,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003425429,0.0006747801,0.002165639,0.0004937035,0.0000702632,0.00001879246,0.000283837,0.0002273157,0.0004904177],"category_scores_gemma":[0.0001225838,0.0004952456,0.0005592665,0.0004970111,0.0001139234,0.000116007,0.0001395592,0.000806556,0.0001543052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005457076,"about_ca_system_score_gemma":0.001109597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004390968,"about_ca_topic_score_gemma":0.00007232872,"domain_scores_codex":[0.9964362,0.0003344209,0.0009857629,0.0006399615,0.0006822718,0.0009214327],"domain_scores_gemma":[0.9982083,0.0002426881,0.0005106678,0.0004802401,0.0001546705,0.0004033687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001150173,0.0006697156,0.003639587,0.02690138,0.0003423633,0.00005320367,0.0001402066,0.000003703915,0.00002540951,0.00003320962,0.0002231311,0.9678531],"study_design_scores_gemma":[0.002691786,0.0001593601,0.001631127,0.03039745,0.001203861,0.00001996226,0.0000610623,0.000230959,0.0002619009,0.00003228546,0.9627145,0.0005957306],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006751259,0.9960306,0.000008850233,0.00002063777,0.0005036665,0.002298402,0.0001816367,0.0000437457,0.000237377],"genre_scores_gemma":[0.02409688,0.9736668,0.00008033166,0.000009442976,0.0003547762,0.0008012715,0.0007163186,0.0001080826,0.0001660534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9672573,"threshold_uncertainty_score":0.9997499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2061342795","doi":"10.2174/156800906777723976","title":"Radiation-Induced Bystander and other Non-Targeted Effects: Novel Intervention Points in Cancer Therapy?","year":2006,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Canada Research Chairs; Irish Research Council; Science Foundation Ireland; Technological University Dublin; National Science Foundation","keywords":"Bystander effect; DNA damage; Radiation therapy; Cancer research; Cancer; Cancer cell; Medicine; Apoptosis; Biology; Immunology; DNA; Genetics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04054962463183979,"gpt":0.3892558936366209,"spread":0.3487062690047811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005195765,0.0008243106,0.00212076,0.0006832464,0.00007951839,0.00005536285,0.0002101773,0.0003833609,0.0002052025],"category_scores_gemma":[0.0001066962,0.0006843702,0.0005329996,0.0006303376,0.00006267482,0.0001965511,0.00005592345,0.0009227481,0.00002347678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00120498,"about_ca_system_score_gemma":0.0005639874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001303899,"about_ca_topic_score_gemma":0.0004470174,"domain_scores_codex":[0.9966915,0.0002709592,0.001042576,0.0009203606,0.0005032449,0.0005713605],"domain_scores_gemma":[0.9981027,0.000264558,0.0008094496,0.0004626583,0.0001385134,0.0002220866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005196456,0.0005052198,0.00395058,0.02485492,0.0004092234,0.000007823291,0.0002974097,0.00000567811,0.00003360245,0.000009653471,0.007365907,0.962508],"study_design_scores_gemma":[0.005929902,0.000122804,0.004953772,0.03456322,0.0007589337,0.000008560456,0.000006923325,0.000146897,0.000128871,0.00001360801,0.9526556,0.0007108866],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00250253,0.9896585,0.00009448038,0.000166417,0.003182217,0.003938447,0.0002814551,0.00009119759,0.0000847011],"genre_scores_gemma":[0.002025094,0.9936504,0.00005588739,0.0001946859,0.001117805,0.002078766,0.0004204513,0.0001882038,0.0002686839],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9617971,"threshold_uncertainty_score":0.9995608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071672251","doi":"10.2174/1568009043333005","title":"Targeting Translation for Treatment of Cancer - A Novel Role for IRES?","year":2004,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Internal ribosome entry site; Translation (biology); Untranslated region; Biology; Eukaryotic translation; Cell biology; Protein biosynthesis; Cancer cell; Cancer; Cancer research; Messenger RNA; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.07399969090101047,"gpt":0.3989401575790323,"spread":0.3249404666780218,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009401311,0.0004283311,0.0008769398,0.00007577043,0.0001145648,0.00001771293,0.0002149932,0.0001988809,0.00002115573],"category_scores_gemma":[0.00001367415,0.0003601451,0.000754389,0.000105258,0.00005073653,0.000005727705,0.00001629815,0.0000490546,7.547097e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002947855,"about_ca_system_score_gemma":0.001098643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001461427,"about_ca_topic_score_gemma":0.0001169158,"domain_scores_codex":[0.9982738,0.00002228424,0.000595792,0.0006408867,0.0001167786,0.0003503855],"domain_scores_gemma":[0.9988211,0.00002850983,0.0005422976,0.0003265472,0.0002016885,0.00007983986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005342572,0.0002380363,0.000005537599,0.009107772,0.0003114949,2.779222e-8,0.0001033703,0.0003882387,0.001306581,0.00004937406,0.0008466773,0.9875895],"study_design_scores_gemma":[0.001231871,0.0001167504,0.000001590085,0.00257571,0.0008215043,3.293835e-7,0.00001191828,0.0001008426,0.001955829,0.00002983785,0.9927754,0.0003784045],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003835143,0.9827155,0.008424952,0.00004373857,0.00106917,0.00275255,0.004931226,0.00001136785,0.0000131118],"genre_scores_gemma":[0.0001409492,0.9829284,0.001273339,0.000006101955,0.001163569,0.01083297,0.003348791,0.00008551858,0.0002203785],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9919288,"threshold_uncertainty_score":0.999885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048425980","doi":"10.2174/1568009043481551","title":"Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications","year":2004,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Signal transduction; Biology; Cancer research; Cancer cell; Apoptosis; Cell biology; Programmed cell death; Cancer; Kinase; Cell signaling; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03671337346671952,"gpt":0.327231160591954,"spread":0.2905177871252345,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002190193,0.0002889846,0.0004228831,0.0000859647,0.0000742767,0.00003677354,0.0001651568,0.000149112,0.00001044917],"category_scores_gemma":[0.000002265994,0.0001861039,0.00008650067,0.0001337587,0.0000570201,0.000003547386,0.00007468033,0.0002085392,4.12767e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006043953,"about_ca_system_score_gemma":0.0001728718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000134094,"about_ca_topic_score_gemma":0.0009815148,"domain_scores_codex":[0.998861,0.0001352827,0.0002403655,0.000438063,0.00007844038,0.0002468805],"domain_scores_gemma":[0.9995636,0.00002031934,0.0001446782,0.0002035738,0.0000262035,0.00004161858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004951237,0.00005237106,0.00002622695,0.002609937,0.00004668499,5.612499e-7,0.0002808255,0.0001039996,0.004803753,0.00008219467,0.00001950093,0.991969],"study_design_scores_gemma":[0.0007377099,0.00005416965,0.0006263402,0.005450807,0.0003664141,0.00001099954,0.0001392122,0.00006650881,0.001957586,0.0006207519,0.9892182,0.0007512399],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001965801,0.9963636,0.0001175815,0.0001634558,0.00058013,0.0006836025,0.0001142322,0.000004229239,0.000007336684],"genre_scores_gemma":[0.03553802,0.9634835,0.000009726397,0.00002856918,0.0003290903,0.0003893709,0.0001744043,0.00002742563,0.00001991706],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912177,"threshold_uncertainty_score":0.7589096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100388782","doi":"10.2174/156800911793743600","title":"Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)","year":2010,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Gemcitabine; Medicine; Internal medicine; Oncology; Regimen; Univariate analysis; Biliary tract; Nucleoside transporter; Cancer; Gastroenterology; Multivariate analysis; Transporter","retraction":null,"screen_n_in":null,"score":{"opus":0.0264076660779159,"gpt":0.3325899278775272,"spread":0.3061822617996113,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002994201,0.0008053468,0.001201285,0.0002573584,0.0001046236,0.00003781963,0.0005575802,0.0003675135,0.0003184597],"category_scores_gemma":[0.00002932591,0.0006243683,0.0003381305,0.0003416976,0.0001016911,0.0000222523,0.000124548,0.0007967553,0.000008025615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001497166,"about_ca_system_score_gemma":0.0009626781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000094404,"about_ca_topic_score_gemma":0.0001869424,"domain_scores_codex":[0.9967619,0.0002531345,0.0008117523,0.001127029,0.0003858288,0.0006603109],"domain_scores_gemma":[0.9985012,0.00003516337,0.0003988598,0.0006140106,0.0001592754,0.0002914329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003101319,0.002822523,0.05787854,0.01301182,0.001227379,0.00008353325,0.001805138,0.0003532727,0.00139907,0.00001764189,0.08291194,0.8353878],"study_design_scores_gemma":[0.001364365,0.0002560109,0.01232255,0.005841458,0.0003582343,0.000001459733,0.000008120375,0.000001491787,0.0002921814,0.000004295931,0.9786578,0.0008919761],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1308805,0.8645997,0.00003592264,0.000070745,0.0008244791,0.001509936,0.00201435,0.00002458785,0.00003977582],"genre_scores_gemma":[0.04727583,0.9461003,0.0001057112,0.0001695522,0.001464415,0.001637504,0.002351148,0.0002692564,0.0006263079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8957459,"threshold_uncertainty_score":0.9996207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2327659954","doi":"10.2174/156800911794519770","title":"Clioquinol – A Novel Copper-Dependent and Independent Proteasome Inhibitor","year":2011,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Clioquinol; Proteasome inhibitor; Proteasome; Pharmacology; Chemistry; Extracellular; Intracellular; Mechanism of action; Prodrug; Cancer research; Biochemistry; Medicine; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.07753226772495421,"gpt":0.3724427619954073,"spread":0.2949104942704531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002481393,0.0006398982,0.001023009,0.0001058435,0.0001658246,0.00005220224,0.0004326931,0.0003496994,0.00007949809],"category_scores_gemma":[0.0001717526,0.0004539509,0.0004079166,0.0001168478,0.0002760808,0.000006432537,0.0009825414,0.0005440683,0.00004470805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008636541,"about_ca_system_score_gemma":0.0006049183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000402329,"about_ca_topic_score_gemma":0.00005612663,"domain_scores_codex":[0.997229,0.0001457773,0.0004915149,0.001103394,0.00031088,0.0007193875],"domain_scores_gemma":[0.9986332,0.00002217075,0.0002650593,0.0004479993,0.0001539857,0.0004775992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008073472,0.000227787,0.0001145188,0.007377145,0.000336852,0.000005260819,0.00002810467,7.557982e-8,0.0001253977,0.00006769784,0.01169895,0.9799375],"study_design_scores_gemma":[0.0004936871,0.0001286661,0.00005143023,0.002389785,0.0002067968,0.000008154555,0.0000127682,3.284644e-7,0.000154657,0.00002880713,0.9959547,0.0005702094],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001647653,0.9959395,0.00002324338,0.0000327127,0.0008460218,0.00165793,0.0009722731,0.00002777774,0.000335782],"genre_scores_gemma":[0.0007554147,0.995025,0.0000306821,0.00003618891,0.001357334,0.001853364,0.000375179,0.00005428883,0.0005124993],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9842557,"threshold_uncertainty_score":0.9997912,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011022421","doi":"10.2174/156800905774574020","title":"Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose","year":2005,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Pharmacology; Drug; Cancer; Drug development; Dosing; Pharmacokinetics; Pharmacodynamics; Cancer research; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01916500562821551,"gpt":0.3107667388099772,"spread":0.2916017331817617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003385146,0.001057509,0.001489538,0.0002261307,0.0002113085,0.00009519922,0.0003601233,0.0004219665,0.00004334475],"category_scores_gemma":[0.00003788331,0.0009233204,0.0004845984,0.0002729884,0.0002611917,0.00002023588,0.0006527365,0.0003246946,0.000007641909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001085373,"about_ca_system_score_gemma":0.0002357312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000935866,"about_ca_topic_score_gemma":0.00005062972,"domain_scores_codex":[0.9964554,0.0002548897,0.0005812527,0.001646801,0.0002341712,0.0008275292],"domain_scores_gemma":[0.9983076,0.00003995025,0.0004067364,0.0005789446,0.0001218787,0.0005448388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001480142,0.00009514067,0.0003228177,0.003012183,0.0005714284,0.00002519962,0.00007008511,0.00001471939,0.02055265,9.871003e-7,0.003495588,0.9716912],"study_design_scores_gemma":[0.0009674932,0.0001512278,0.0004991001,0.001669934,0.0008946509,0.0000226455,0.0000192256,0.0001005906,0.01555058,0.000001979917,0.97863,0.001492587],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2126124,0.7848227,0.00009797842,0.0000635951,0.000700174,0.001061734,0.0006069493,0.00002572834,0.000008739017],"genre_scores_gemma":[0.05455694,0.942889,0.0005015159,0.00007411564,0.00079246,0.0004272743,0.000473013,0.0001318377,0.0001538881],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9751344,"threshold_uncertainty_score":0.9993218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111967651","doi":"10.2174/156800905774574011","title":"Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications","year":2005,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer research; Biology; DNA methylation; Prostate cancer; Epigenetics; Gene silencing; Cancer; Urokinase receptor; Metastasis; Breast cancer; Tumor progression; Gene; Plasminogen activator; Gene expression; Endocrinology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03075453478558431,"gpt":0.3526805359875418,"spread":0.3219260012019575,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000190026,0.0003062181,0.0005347684,0.0001445754,0.00004828373,0.00002284328,0.0001108221,0.0001504772,0.000008617873],"category_scores_gemma":[0.00001821831,0.0002689043,0.00008823128,0.000188621,0.00009356224,0.000006167325,0.00009335862,0.000174987,5.5171e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005231227,"about_ca_system_score_gemma":0.0002782719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005558241,"about_ca_topic_score_gemma":0.0001384804,"domain_scores_codex":[0.9985365,0.0001216665,0.0004726009,0.0005244687,0.0001069408,0.00023781],"domain_scores_gemma":[0.9991636,0.00002829724,0.0003666342,0.0002467447,0.0001087229,0.00008603297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001116725,0.00006788604,0.007451814,0.002943064,0.00004857901,1.538635e-7,0.00009209773,0.00001089114,0.0005344626,0.000009619775,0.00002446048,0.9888058],"study_design_scores_gemma":[0.0004725574,0.00005928289,0.01899368,0.003292656,0.0004109477,0.000005200171,0.000005827532,0.00004429259,0.000466412,0.0001566103,0.9755898,0.0005028107],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01762656,0.9803956,0.00002743811,0.0001362612,0.0001737074,0.001142935,0.0004761674,0.000006168292,0.00001521902],"genre_scores_gemma":[0.02767587,0.970939,0.00006615998,0.000007430056,0.0002108852,0.0006700919,0.0003512685,0.00004108456,0.00003814388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.988303,"threshold_uncertainty_score":0.9999763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164239756","doi":"10.2174/156800912802429292","title":"Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma","year":2012,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Stromal cell; Multiple myeloma; Syngenic; In vivo; Cancer research; Bone marrow; Tumor microenvironment; Medicine; Biology; Immunology; Tumor cells","retraction":null,"screen_n_in":null,"score":{"opus":0.3272550846793235,"gpt":0.4419032954217033,"spread":0.1146482107423798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003307953,0.0005101683,0.001287136,0.0002678758,0.0001283357,0.00001602713,0.000318564,0.0001489183,0.0002391041],"category_scores_gemma":[0.00003195605,0.000312568,0.0005101025,0.000259035,0.0000616637,0.0001432127,0.0000606313,0.0004146212,0.00003429391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005004402,"about_ca_system_score_gemma":0.002937815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001366987,"about_ca_topic_score_gemma":0.0004586316,"domain_scores_codex":[0.9972474,0.00004893872,0.0009115596,0.0004320869,0.0006812569,0.0006787835],"domain_scores_gemma":[0.9984798,0.0003903839,0.0003166275,0.0003726534,0.0001138409,0.0003267278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002250096,0.0004066946,0.0004673617,0.009295558,0.0008311376,0.000001421252,0.001658306,0.00002352697,5.665183e-7,0.00007170559,0.0003147103,0.986704],"study_design_scores_gemma":[0.003765169,0.00003051143,0.0007080025,0.005773851,0.0008415593,0.000003996906,0.00002853391,0.001497228,0.00006170089,0.0001288371,0.9868537,0.00030687],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002426074,0.9928976,0.001051683,0.00006683099,0.0004695566,0.004888745,0.0003047251,0.00002255904,0.00005573677],"genre_scores_gemma":[0.004702619,0.9896687,0.001153884,0.00001709437,0.0003090489,0.002471996,0.0009201568,0.00008573235,0.0006707905],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.986539,"threshold_uncertainty_score":0.9999326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003470917","doi":"10.2174/156800908786733450","title":"Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma","year":2008,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada; Memorial Sloan-Kettering Cancer Center","keywords":"Pazopanib; Temsirolimus; Sunitinib; Axitinib; Sorafenib; Everolimus; Medicine; Vascular endothelial growth factor; Cancer research; Renal cell carcinoma; Bevacizumab; Platelet-derived growth factor receptor; Angiogenesis; PI3K/AKT/mTOR pathway; Tyrosine-kinase inhibitor; Growth factor; Pharmacology; Internal medicine; Cancer; Biology; Signal transduction; VEGF receptors; Discovery and development of mTOR inhibitors; Receptor; Chemotherapy; Hepatocellular carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.05341450169617008,"gpt":0.340254233950875,"spread":0.2868397322547049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000147578,0.001238377,0.003919643,0.0005582254,0.0001133499,0.00001515725,0.0005097659,0.0002414904,0.0001625576],"category_scores_gemma":[0.00001492072,0.0007401014,0.002216505,0.0008315026,0.0001912822,0.0000772718,0.00006461782,0.0005119179,0.00007767308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001887717,"about_ca_system_score_gemma":0.001441223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002556343,"about_ca_topic_score_gemma":0.00005874352,"domain_scores_codex":[0.9952867,0.0003913526,0.001454069,0.001107909,0.0008595969,0.0009003677],"domain_scores_gemma":[0.9971185,0.0002311916,0.0008938216,0.001329954,0.0001537847,0.0002727821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009543716,0.002959661,0.001369023,0.01257236,0.0003774599,0.000701787,0.002099203,0.00001973067,0.00001631044,0.000005076172,0.005521516,0.9742624],"study_design_scores_gemma":[0.002785999,0.000663529,0.001792998,0.005236323,0.002416053,0.0001564971,0.00005128332,0.000004273903,0.0008296036,0.000004326208,0.9854802,0.0005788764],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01100677,0.9824006,0.000002097555,0.00006092109,0.001256636,0.004227939,0.0004013098,0.00003854488,0.0006051586],"genre_scores_gemma":[0.01232887,0.9834105,0.0001027491,0.00001965634,0.0006575613,0.001832558,0.001102444,0.0001383447,0.0004072752],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9799587,"threshold_uncertainty_score":0.999505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149276366","doi":"10.2174/156800906778194586","title":"Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers","year":2006,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Drug; Medicine; Intensive care medicine; Drug development; Pharmacology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.05245195177791379,"gpt":0.3971150038702496,"spread":0.3446630520923358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002041805,0.0002850007,0.0006543496,0.0001441771,0.00008258977,0.00001659436,0.000144893,0.00008893289,0.000005390692],"category_scores_gemma":[0.00001905128,0.000210033,0.0001687172,0.0001272474,0.0002027073,0.000006132718,0.00005049264,0.0001133726,1.235232e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000359829,"about_ca_system_score_gemma":0.001430779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003016081,"about_ca_topic_score_gemma":0.001205081,"domain_scores_codex":[0.998424,0.0001556825,0.0005434229,0.0004059968,0.0002427778,0.0002281082],"domain_scores_gemma":[0.9987975,0.00009320019,0.0006614035,0.0002067375,0.0001853967,0.00005572156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004312664,0.001202518,0.0008374131,0.009587429,0.0004543791,0.0000036775,0.0006032726,0.0000202327,0.00009400341,0.000165738,0.008983321,0.9780049],"study_design_scores_gemma":[0.001206149,0.00006815889,0.0005002124,0.002197426,0.000151132,0.000006470875,0.00004015607,0.00003301879,0.0006627947,0.000004893945,0.994916,0.0002135886],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02331028,0.9730863,0.00002922648,0.00002289627,0.0002322992,0.001461443,0.00184113,0.00000215001,0.00001430699],"genre_scores_gemma":[0.002833806,0.9923214,0.0005911447,0.000002646531,0.0000853208,0.001557481,0.002453181,0.00002562721,0.0001293901],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9859326,"threshold_uncertainty_score":0.8564895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121862563","doi":"10.2174/1568009615666150105115047","title":"Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer","year":2015,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Health Authority","funders":"","keywords":"Drug delivery; Breast cancer; Monoclonal antibody; Nanotechnology; Targeted drug delivery; Nanomedicine; Drug; Cancer; Dendrimer; Liposome; Cancer therapy; Flexibility (engineering); Medicine; Pharmacology; Nanoparticle; Chemistry; Materials science; Antibody; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06493306173260915,"gpt":0.3781428014225207,"spread":0.3132097396899116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001330404,0.001093066,0.002376525,0.0005044882,0.000270784,0.0001768965,0.001075559,0.0002797479,0.0007459261],"category_scores_gemma":[0.00006785054,0.0009748563,0.0006854473,0.0009330399,0.0002239986,0.0006891803,0.0003645579,0.0007132959,0.0003539579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002940776,"about_ca_system_score_gemma":0.003889095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005274055,"about_ca_topic_score_gemma":0.000717656,"domain_scores_codex":[0.9937285,0.0004785321,0.001692826,0.001482484,0.0008798633,0.001737755],"domain_scores_gemma":[0.9966857,0.0003863502,0.0007750944,0.0007605773,0.0006704501,0.0007218718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001378983,0.0005364884,0.0001269233,0.01283771,0.0000985078,0.00001494131,0.0003808662,0.0006218715,0.0007359186,0.0000544767,0.06726806,0.9171863],"study_design_scores_gemma":[0.00155686,0.00001017762,0.00001254677,0.009378751,0.0006800761,0.000005349785,0.0000230152,0.001073295,0.001293332,0.00008492308,0.9846745,0.00120715],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005698183,0.9729941,0.00003521103,0.0003782402,0.008001193,0.003295642,0.009329639,0.0002344856,0.00003333413],"genre_scores_gemma":[0.001553137,0.990689,0.0002604157,0.0001783969,0.001349512,0.004917108,0.0006855476,0.0002066403,0.0001602593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9174064,"threshold_uncertainty_score":0.9992702,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112773270","doi":"10.2174/156800912801784857","title":"Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents","year":2012,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Myristoylation; Biology; Kinase; Cancer; Cancer research; Carcinogenesis; Cancer cell; Pharmacology; Biochemistry; Phosphorylation","retraction":null,"screen_n_in":null,"score":{"opus":0.08981349512724712,"gpt":0.418618193008455,"spread":0.3288046978812079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000246362,0.0004265971,0.0007346877,0.0001924012,0.00005828049,0.00001859022,0.0002274816,0.0002311354,0.0001593345],"category_scores_gemma":[0.00002934275,0.0003885088,0.0002722922,0.0003048976,0.00007718236,0.00001707118,0.0001483936,0.0003604642,0.00002192525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003344806,"about_ca_system_score_gemma":0.0008108598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004279832,"about_ca_topic_score_gemma":0.00008896941,"domain_scores_codex":[0.9978018,0.0002328854,0.0008067338,0.0005212697,0.0002474957,0.0003898259],"domain_scores_gemma":[0.9986402,0.00001251963,0.0007194767,0.0003995618,0.0001569609,0.00007131088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003782659,0.0002107534,0.0001667005,0.02021394,0.0001389828,0.00000108535,0.0001062678,0.000004154668,0.0005244071,0.00007868273,0.0005737545,0.9779434],"study_design_scores_gemma":[0.0003474341,0.00002266357,0.00006031146,0.01364294,0.0001109731,0.00000280852,0.000004904618,0.000002660003,0.00451883,0.0000386366,0.9808397,0.0004081272],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008286437,0.9517963,0.0003720601,0.00003174191,0.0006043078,0.04686669,0.0000849131,0.00001383991,0.0001472935],"genre_scores_gemma":[0.0009250335,0.7676203,0.0002438403,0.00002076564,0.0005836224,0.2300835,0.0002979712,0.00007295744,0.0001519725],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.980266,"threshold_uncertainty_score":0.9998567,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027556747","doi":"10.2174/156800910791859452","title":"Antisense Treatment in Human Prostate Cancer and Melanoma","year":2010,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Victoria Hospital; Western University","funders":"Canadian Institutes of Health Research; Francis Crick Institute","keywords":"Prostate cancer; Antisense therapy; Clusterin; Cancer; Cancer research; RNA; Medicine; Prostate; Biology; Internal medicine; Gene; Apoptosis; Locked nucleic acid; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05579727939079897,"gpt":0.4177648667764648,"spread":0.3619675873856658,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001255591,0.0007007988,0.002265143,0.0003530004,0.00008035255,0.00002517221,0.0001335288,0.0002487434,0.000332563],"category_scores_gemma":[0.00002446722,0.0005400537,0.0003112754,0.0002158262,0.0002024542,0.00004731007,0.000151108,0.000712981,0.00002446925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008238391,"about_ca_system_score_gemma":0.0008969108,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004984402,"about_ca_topic_score_gemma":0.001417124,"domain_scores_codex":[0.9974715,0.0001238648,0.0007056222,0.0009136544,0.0002114484,0.0005739427],"domain_scores_gemma":[0.9986181,0.00005976175,0.0003534212,0.0005668476,0.00006630158,0.0003355325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000329223,0.0002765661,0.005272986,0.0176127,0.0001117098,0.000300242,0.0004580533,2.861424e-7,0.00001083047,0.000008264959,0.001219788,0.9746956],"study_design_scores_gemma":[0.001637279,0.00007395347,0.00148802,0.0174007,0.001395521,0.00008591294,0.000008541989,0.00000426311,0.00001403774,0.00001561844,0.9774153,0.0004608534],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01558462,0.9779567,1.570029e-7,0.0001563461,0.002454985,0.00280731,0.000828857,0.00006112631,0.0001498794],"genre_scores_gemma":[0.0003335857,0.9942616,0.00002634556,0.00002972514,0.0007508234,0.002998957,0.0004423303,0.0001111827,0.001045448],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9761955,"threshold_uncertainty_score":0.9997051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W131285836","doi":"10.2174/156800907780058844","title":"Oncolytic Viruses: Whats Next?","year":2007,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada","funders":"","keywords":"Oncolytic virus; Exploit; Cancer; Biology; Computational biology; Virus; Computer science; Virology; Computer security; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1284561124885577,"gpt":0.4518016595399557,"spread":0.323345547051398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006244954,0.0007982968,0.001262321,0.0002618078,0.0001523606,0.0001190959,0.001056988,0.0004280883,0.0003990121],"category_scores_gemma":[0.00005932877,0.0007072112,0.0007903271,0.0004118459,0.000176126,0.00001120433,0.0003735541,0.0007679769,0.0003604578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003565164,"about_ca_system_score_gemma":0.001924859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002952586,"about_ca_topic_score_gemma":0.000361204,"domain_scores_codex":[0.9962766,0.0002857864,0.0007369852,0.001151922,0.0005539353,0.0009947792],"domain_scores_gemma":[0.9979056,0.00004998913,0.0003771083,0.001105263,0.0001873373,0.0003747151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001536107,0.0001232696,0.000004767071,0.004836812,0.0002646945,0.000008769518,0.00002540524,0.000004317074,0.0001534965,0.000003567874,0.0217275,0.9726938],"study_design_scores_gemma":[0.0003819145,0.0002815396,6.432805e-7,0.003925312,0.0002326048,0.000006671343,0.000008796121,0.000002957696,0.001588251,0.000009374593,0.9928063,0.0007556104],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001749931,0.995352,0.00004144564,0.00001903055,0.002544019,0.001237366,0.0002206412,0.00004169399,0.0003688554],"genre_scores_gemma":[0.00002444041,0.9946266,0.00003070291,0.0001765189,0.00274475,0.0005857764,0.0006776039,0.0001939986,0.0009396393],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9719382,"threshold_uncertainty_score":0.9995379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206024180","doi":"10.2174/1568009622666211231140623","title":"The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Current Cancer Drug Targets","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Institute of Infection and Immunity; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Triple-negative breast cancer; Natural (archaeology); Breast cancer; Medicine; Cancer; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01021136430356674,"gpt":0.2927029449318295,"spread":0.2824915806282628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008759313,0.000118633,0.0001432697,0.00001676811,0.00007914883,0.000010174,0.0002149494,0.00003407188,0.00002125939],"category_scores_gemma":[0.00003355756,0.000067707,0.00008699862,0.0002562266,0.0002640882,0.000002799125,0.00004469155,0.0000745514,7.758286e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005036965,"about_ca_system_score_gemma":0.00038816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003010564,"about_ca_topic_score_gemma":0.0009815464,"domain_scores_codex":[0.9990528,0.00008189459,0.0002329747,0.0002661526,0.0001857735,0.0001804045],"domain_scores_gemma":[0.9992487,0.00002371968,0.0001337391,0.000335533,0.0002296677,0.000028611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003727576,0.001976797,0.005553901,0.000171965,0.0003312911,0.000004118985,0.002767768,0.00005848219,0.6228556,0.000292671,0.0228462,0.3427684],"study_design_scores_gemma":[0.001441821,0.00006459381,0.05029859,0.00005489965,0.00007933336,0.000007704548,0.0004878514,0.00007884862,0.7306086,0.0001795718,0.2165277,0.0001705237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.892844,0.09607264,0.00003163759,0.00840838,0.001382913,0.0005870226,0.0006320325,0.000003840234,0.00003751523],"genre_scores_gemma":[0.9871562,0.01162341,0.00003831323,0.00003322259,0.0004121484,0.0003369495,0.0001245065,0.00000805764,0.0002671791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3425979,"threshold_uncertainty_score":0.2761011,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2422973035","doi":"10.2174/1568009615666150616123548","title":"Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous","year":2015,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Drug delivery; Medicine; Blood–brain barrier; Glioblastoma; Chemotherapy; Radiation therapy; Brain tumor; Central nervous system; Surgery; Pathology; Internal medicine; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.05580880027447598,"gpt":0.3625731993795175,"spread":0.3067643991050415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002052936,0.0007347167,0.00173413,0.0001620447,0.0001452035,0.0001273121,0.0003656386,0.0001552106,0.000317799],"category_scores_gemma":[0.000009385432,0.0004160016,0.0006741992,0.0003338071,0.00006288402,0.00009174872,0.00008736447,0.0004032128,0.0003812727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001516305,"about_ca_system_score_gemma":0.001858741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004304795,"about_ca_topic_score_gemma":0.0001100237,"domain_scores_codex":[0.9971699,0.0001366248,0.0006106881,0.0006910377,0.0006894995,0.0007023062],"domain_scores_gemma":[0.9983014,0.00006367618,0.0002416563,0.0006378307,0.000277658,0.0004777038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004036027,0.0003510343,0.0001427168,0.008102519,0.0006678393,0.00005813519,0.0004553357,0.00005252213,4.205395e-7,0.0001636839,0.09594886,0.8940166],"study_design_scores_gemma":[0.0008786225,0.00007112141,0.0003703785,0.01221437,0.001669259,0.00007819363,0.000194392,0.00001989583,0.000003889622,0.000003860702,0.984099,0.0003970357],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007353997,0.9908972,0.00001171653,0.0007685719,0.003750155,0.002744049,0.0006349867,0.0001094801,0.0003484098],"genre_scores_gemma":[0.001171423,0.9934329,0.000065251,0.0001410485,0.002532843,0.001864491,0.000486967,0.0001185629,0.0001864519],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8936195,"threshold_uncertainty_score":0.9998292,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2786620549","doi":"10.2174/1568009617666170206111609","title":"Oncolytic Viruses: The Best is Yet to Come","year":2018,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Virotherapy; Tumor microenvironment; Medicine; Immune system; Immune modulation; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09197668856040245,"gpt":0.4374924473297759,"spread":0.3455157587693735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000493642,0.000622923,0.0009066737,0.0001289587,0.0002281827,0.00008881364,0.001507952,0.0002369844,0.0004458639],"category_scores_gemma":[0.00007123512,0.0004278973,0.0005595895,0.000390778,0.000219517,0.000003950984,0.0005798056,0.0004978235,0.001323692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002378518,"about_ca_system_score_gemma":0.001326315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005299702,"about_ca_topic_score_gemma":0.000361211,"domain_scores_codex":[0.9969717,0.0003178885,0.0005339653,0.000970936,0.0004709102,0.0007346001],"domain_scores_gemma":[0.997797,0.00004190808,0.0002479319,0.001393141,0.0002209962,0.0002990127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000115968,0.000103729,0.000008212947,0.002227928,0.0002980455,0.000001769368,0.0001078906,0.000001917142,0.0001237201,0.000002346,0.2556629,0.7413456],"study_design_scores_gemma":[0.0002146947,0.0005014924,4.536409e-7,0.00287028,0.0002287232,0.00000349666,0.00001335992,0.000002052562,0.002157061,0.0000102439,0.9934742,0.0005238684],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004312483,0.9943194,0.00001307879,0.0002156805,0.002308558,0.00161326,0.0008223252,0.00001858605,0.0002578726],"genre_scores_gemma":[0.00004677362,0.9932629,0.00001534852,0.0008667113,0.002421872,0.001151564,0.0002433942,0.0001350051,0.00185645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7408217,"threshold_uncertainty_score":0.9998173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107103889","doi":"10.2174/156800909789760393","title":"Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy","year":2009,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Comprehensive Cancer Network","keywords":"Multiple myeloma; Medicine; Bone disease; Disease; Current (fluid); Intensive care medicine; Bioinformatics; Osteoporosis; Internal medicine; Biology; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.1661181867633645,"gpt":0.3756281219796366,"spread":0.2095099352162721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003954218,0.001449095,0.002774475,0.0005312486,0.0004355263,0.0001369483,0.0008528505,0.0001805983,0.0004564276],"category_scores_gemma":[0.0002556983,0.0008907869,0.001193068,0.00110439,0.0001120237,0.0001225487,0.0003560258,0.00157063,0.0006810061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001008636,"about_ca_system_score_gemma":0.001127426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002078936,"about_ca_topic_score_gemma":0.00004978796,"domain_scores_codex":[0.9937734,0.0003671495,0.0011886,0.001805798,0.001341507,0.001523543],"domain_scores_gemma":[0.9955438,0.0004167237,0.0004022577,0.001489337,0.0001751836,0.001972706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003234513,0.0009309786,0.0004299562,0.00309337,0.0009103858,0.0001004655,0.0006235029,0.00004421324,6.19783e-7,0.00003248416,0.006750384,0.9867602],"study_design_scores_gemma":[0.001915188,0.00009207131,0.003181274,0.01901213,0.0007273949,0.000005484567,0.00002123848,0.0003357101,0.00002360311,0.0001197395,0.9736944,0.0008717243],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003566296,0.9845316,0.00007410871,0.002412718,0.002317266,0.008117751,0.001871416,0.0002477415,0.00007074102],"genre_scores_gemma":[0.002222998,0.9878216,0.0002972019,0.0001227836,0.00101247,0.004612209,0.003226398,0.0002201996,0.0004641227],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9858885,"threshold_uncertainty_score":0.9998259,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990604167","doi":"10.2174/156800908785699306","title":"Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer","year":2008,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Epigenetics; Malignancy; Esophageal cancer; Biology; Esophagus; Disease; Epigenetic therapy; Cancer; Cancer research; Carcinogenesis; Somatic evolution in cancer; Bioinformatics; Carcinoma; Medicine; Genetics; Pathology; Internal medicine; Gene; DNA methylation; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.04657069195341299,"gpt":0.3657157121025971,"spread":0.3191450201491841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001377906,0.0006402807,0.001165899,0.0001771779,0.0001696432,0.00002428542,0.000347906,0.00034094,0.0001186288],"category_scores_gemma":[0.00003777383,0.0005723895,0.0004346157,0.0002720987,0.0002273408,0.000005766172,0.0001451876,0.0002923398,0.000005899424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006217926,"about_ca_system_score_gemma":0.0008588034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001191592,"about_ca_topic_score_gemma":0.0001128748,"domain_scores_codex":[0.9972878,0.0002489153,0.0008640505,0.0008558735,0.0002921618,0.000451252],"domain_scores_gemma":[0.9982803,0.00004199461,0.0006638683,0.0005793922,0.0002316923,0.000202679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001195949,0.0001099524,0.0005255202,0.001741238,0.0002685336,0.000001340491,0.0001333665,0.00008435512,0.001001091,0.000007545659,0.001364053,0.994751],"study_design_scores_gemma":[0.0004079106,0.00007618532,0.00053191,0.001187036,0.0001797638,0.000002187468,0.000004089592,0.00001373743,0.008250888,0.00004105013,0.9887363,0.0005689919],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003055449,0.9936811,0.0002111028,0.00002246369,0.001446634,0.001005905,0.0004988843,0.00001556857,0.00006283331],"genre_scores_gemma":[0.00243785,0.994702,0.0001684318,0.00001558277,0.0008177959,0.0006440763,0.000837559,0.0001077502,0.0002689717],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9941821,"threshold_uncertainty_score":0.9996728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058472600","doi":"10.2174/1568009054629672","title":"Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway","year":2005,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Ubiquitin ligase; Carcinogenesis; Hypoxia-inducible factors; Biology; Cancer research; Ubiquitin; Transcription factor; Vascular endothelial growth factor; Angiogenesis; Tumor suppressor gene; HIF1A; Cell biology; Cancer; Gene; Genetics; VEGF receptors","retraction":null,"screen_n_in":null,"score":{"opus":0.03926531878117005,"gpt":0.3508890844591312,"spread":0.3116237656779611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003609313,0.00109229,0.00187006,0.0001171926,0.0003327932,0.00008427825,0.000863571,0.0003769612,0.00005402446],"category_scores_gemma":[0.0001408359,0.0007780147,0.001121688,0.0002662967,0.0002516282,0.0000112058,0.0006485404,0.000733868,0.0000605278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000293935,"about_ca_system_score_gemma":0.0009475246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002533046,"about_ca_topic_score_gemma":0.0007096768,"domain_scores_codex":[0.9959859,0.0003940044,0.0009096546,0.001410607,0.0004830671,0.0008168251],"domain_scores_gemma":[0.9974855,0.00006481388,0.0006643214,0.001252244,0.0002964454,0.000236652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001341891,0.00004783618,9.818785e-7,0.001449748,0.0008966812,0.00000386154,0.0005617073,0.00002221166,0.0005293589,0.00001770924,0.03921061,0.9572459],"study_design_scores_gemma":[0.0003615425,0.00001760021,0.000002328984,0.002784483,0.0009798015,0.000005704646,0.00008712387,0.0000061504,0.001420957,0.00008244594,0.9933226,0.0009293362],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002515345,0.9825177,0.0001355308,0.0002415543,0.01522745,0.001023245,0.0004563853,0.00004824243,0.00009837486],"genre_scores_gemma":[0.00008649605,0.9820989,0.0002791042,0.0003275436,0.01514545,0.0003457198,0.001092089,0.0001753723,0.0004492946],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9563165,"threshold_uncertainty_score":0.9994671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098122970","doi":"10.2174/156800910791208571","title":"Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent","year":2010,"lang":"en","type":"article","venue":"Current Cancer Drug Targets","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Poly ADP ribose polymerase; Gene silencing; PARP inhibitor; Temozolomide; Cancer research; Biology; Chemistry; Molecular biology; Polymerase; Biochemistry; DNA; Glioma; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02492817481694091,"gpt":0.3460347325329664,"spread":0.3211065577160255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006357144,0.0004326689,0.0008356595,0.0003688657,0.0001234083,0.00002259399,0.0001033392,0.0001302306,0.0002710028],"category_scores_gemma":[0.0002855456,0.0004125751,0.000131353,0.0007874166,0.0001712614,0.0002094177,0.0001301196,0.0008544084,0.00001434337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004810019,"about_ca_system_score_gemma":0.0003607975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001755344,"about_ca_topic_score_gemma":0.0004878447,"domain_scores_codex":[0.9971657,0.0002724274,0.0005699477,0.0008504005,0.0005064321,0.0006350256],"domain_scores_gemma":[0.9982274,0.000332271,0.0003117786,0.0002575467,0.0002384702,0.0006325534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001691403,0.0008006868,0.007591046,0.0001468832,0.00006040483,0.00003611139,0.001379409,0.00006464971,0.9523956,0.000005398167,0.002205822,0.03362265],"study_design_scores_gemma":[0.003158976,0.0002360702,0.04173513,0.0004686856,0.0001035019,0.00001300642,0.0001117795,0.0003305864,0.9527244,0.00003619867,0.0006872045,0.00039449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922184,0.001916129,0.0002950334,0.002594876,0.00089268,0.001582225,0.0003260765,0.00008961488,0.00008498015],"genre_scores_gemma":[0.9968337,0.0002748098,0.00085089,0.0007561891,0.0007216307,0.000461148,0.00002647862,0.00004137682,0.00003375159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03414408,"threshold_uncertainty_score":0.9998326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135938421","doi":"10.2174/156800911796798922","title":"Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia","year":2011,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Epigenetics; Vorinostat; Histone deacetylase; Cancer research; Biology; Epigenetic therapy; Histone; Carcinogenesis; Leukemia; DNA methylation; Immunology; Cancer; Genetics; Gene expression; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.03725352666084189,"gpt":0.3658097348730264,"spread":0.3285562082121845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000528348,0.001291276,0.002023947,0.000402168,0.0002187772,0.00005509116,0.001128213,0.0007795808,0.0001652473],"category_scores_gemma":[0.0002372283,0.001262363,0.0008375035,0.0007010713,0.0004079031,0.0000211291,0.0008151762,0.00126384,0.00024945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002414501,"about_ca_system_score_gemma":0.003707712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003841442,"about_ca_topic_score_gemma":0.0002571752,"domain_scores_codex":[0.9938672,0.0005323897,0.001645665,0.001867035,0.0005840526,0.001503689],"domain_scores_gemma":[0.997395,0.00006801832,0.0007800108,0.001118527,0.0002440594,0.0003944252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001037179,0.0004253016,0.00003723138,0.01359622,0.0005476383,0.0001143968,0.000724598,0.000131911,0.00121584,0.00002990796,0.1258039,0.8572693],"study_design_scores_gemma":[0.000699754,0.00007929683,0.000001980806,0.00646426,0.0004169719,0.00002162829,0.00001831961,0.00002076618,0.005311572,0.00001452071,0.9856672,0.001283697],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001943362,0.9914324,0.0001569029,0.0000135325,0.004059831,0.001535004,0.0004865163,0.00005576459,0.0003166953],"genre_scores_gemma":[0.0003544561,0.9931684,0.0003304467,0.00002931237,0.001828752,0.001160957,0.001721733,0.0003239034,0.001082042],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8598634,"threshold_uncertainty_score":0.9999839,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220827996","doi":"10.2174/1568009622666220317091723","title":"Current Treatment and Future Trends of Immunotherapy in BreastCancer","year":2022,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Medicine; Breast cancer; Clinical trial; Metastatic breast cancer; Oncology; Cancer; Immune checkpoint; Disease; Cancer immunotherapy; Blockade; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04692936036399204,"gpt":0.3792937953587975,"spread":0.3323644349948054,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002671858,0.0008114536,0.002692062,0.0007961501,0.00008706094,0.00001795733,0.0002376936,0.0001487572,0.003986042],"category_scores_gemma":[0.000003137934,0.0006073198,0.0009378347,0.001028738,0.0001516722,0.00007227362,0.00007792885,0.0006733426,0.000002592273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002129476,"about_ca_system_score_gemma":0.001319828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000472651,"about_ca_topic_score_gemma":0.0001795415,"domain_scores_codex":[0.996941,0.0002036079,0.001083115,0.0008063766,0.0004006896,0.000565184],"domain_scores_gemma":[0.9984561,0.00007340273,0.0006654023,0.000601541,0.00004285938,0.00016074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005441877,0.000608685,0.0002961962,0.009514443,0.0005752324,0.000007068141,0.0006527573,2.573752e-7,0.000001739731,0.00001184065,0.002160015,0.9856276],"study_design_scores_gemma":[0.003566162,0.0002186891,0.0005500664,0.01106513,0.0007375717,0.00003356495,0.0000472106,0.000002165093,0.000004966016,0.000004664239,0.9832665,0.0005033271],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001224597,0.9929475,6.345275e-7,0.0002136195,0.004613942,0.00109747,0.0007638476,0.00003853425,0.000201965],"genre_scores_gemma":[0.00002208503,0.9961995,0.00001279788,0.000026211,0.001213653,0.00158709,0.0005642402,0.0001045556,0.0002698708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9851242,"threshold_uncertainty_score":0.9996378,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028643899","doi":"10.2174/1568009043481542","title":"Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents","year":2004,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"SMAD; Transforming growth factor; Smad2 Protein; Signal transduction; Growth differentiation factor; Breast cancer; Cancer research; Receptor; Biology; Transforming growth factor beta; Cancer; Cell biology; Bone morphogenetic protein; Biochemistry; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04984810400057648,"gpt":0.3837874887530944,"spread":0.3339393847525179,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002564269,0.0007602551,0.000870031,0.0001581474,0.0001872502,0.00006733712,0.0003908013,0.0003006512,0.000402166],"category_scores_gemma":[0.00005656097,0.0006921437,0.0004853675,0.0002002156,0.0001515689,0.00002179395,0.00013498,0.0002822396,0.00002011238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004948856,"about_ca_system_score_gemma":0.002441654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003061984,"about_ca_topic_score_gemma":0.0001529101,"domain_scores_codex":[0.9969123,0.0002716051,0.0006132482,0.001107858,0.0005480046,0.0005469671],"domain_scores_gemma":[0.9986416,0.00002476582,0.0003623585,0.0003911625,0.0002932212,0.0002869262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005078938,0.0001562551,0.0004122706,0.01413871,0.0009987847,0.000001624071,0.0002696038,0.00001574324,0.0002338852,0.000003180004,0.001451773,0.9822674],"study_design_scores_gemma":[0.001015655,0.0000291774,0.0004933438,0.01942113,0.002170552,0.00001597005,0.00002552572,0.000004727782,0.001109318,0.00004709469,0.9745416,0.001125914],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01032764,0.9838514,0.00006119399,0.00002363169,0.001582807,0.001783944,0.00229315,0.00003224261,0.00004403101],"genre_scores_gemma":[0.009632625,0.9860779,0.00003163004,0.00002280446,0.000611401,0.001253058,0.002145053,0.0001190279,0.0001065179],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9811414,"threshold_uncertainty_score":0.999553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3159431400","doi":"10.2174/1568009621666210504085527","title":"Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib","year":2021,"lang":"en","type":"article","venue":"Current Cancer Drug Targets","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Carfilzomib; Proteasome inhibitor; Rhabdomyosarcoma; Cancer research; Pediatric cancer; Cytotoxic T cell; Medicine; Cisplatin; Cytotoxicity; Proteasome; Pharmacology; Cancer; Chemotherapy; In vitro; Multiple myeloma; Sarcoma; Chemistry; Immunology; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01210334658763111,"gpt":0.2681947009137369,"spread":0.2560913543261057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002201352,0.0001938076,0.0001800454,0.00003424075,0.0001155252,0.00003801284,0.0001329252,0.00007958611,0.00004091405],"category_scores_gemma":[0.00007822403,0.0001618195,0.00006019895,0.0001709507,0.00005649347,0.00001034739,0.0001598409,0.0002152916,0.000004062339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004192391,"about_ca_system_score_gemma":0.0002094562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003754773,"about_ca_topic_score_gemma":0.00008807059,"domain_scores_codex":[0.9986649,0.0001410812,0.0002501031,0.0004575342,0.0001697939,0.0003166467],"domain_scores_gemma":[0.9994535,0.00001162756,0.0001071441,0.0002384878,0.00009264031,0.00009659374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001408648,0.0003851541,0.2035034,0.0004802726,0.00004573256,0.0000125016,0.001074228,0.0005341336,0.7519463,0.00008159014,0.02955113,0.01224472],"study_design_scores_gemma":[0.0009582663,0.00004444204,0.02788016,0.00005579359,0.00001721951,0.000008146932,0.00007124521,0.0006223249,0.9437935,0.0003623413,0.02578694,0.0003996475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9549469,0.04320648,0.0001768863,0.0004536399,0.0004101977,0.0005010557,0.0001749959,0.00001374532,0.0001160598],"genre_scores_gemma":[0.9957514,0.002453866,0.00008849859,0.0001274165,0.0007941978,0.000325641,0.0002355101,0.0000223133,0.0002011518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1918472,"threshold_uncertainty_score":0.6598809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065979573","doi":"10.2174/156800911795538129","title":"Redox Environment and its Meaning for Breast Cancer Cells Fate","year":2011,"lang":"en","type":"review","venue":"Current Cancer Drug Targets","topic":"Free Radicals and Antioxidants","field":"Chemistry","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Redox; Cell biology; Intracellular; Oxidative stress; Signal transduction; Biology; Biochemistry; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04647041995451096,"gpt":0.3082267230743886,"spread":0.2617563031198776,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001363893,0.0007402133,0.001467351,0.00006982059,0.0001774641,0.00004949564,0.0004369467,0.0002492861,0.003014915],"category_scores_gemma":[0.000007005374,0.0006183911,0.0004686704,0.00006736728,0.00009177002,0.0001031599,0.0001977794,0.0005198778,0.00005085759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003396932,"about_ca_system_score_gemma":0.0002604777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006546886,"about_ca_topic_score_gemma":0.00001744457,"domain_scores_codex":[0.997413,0.00003294949,0.0006715567,0.000961837,0.0002523221,0.0006683511],"domain_scores_gemma":[0.9986222,0.00006070718,0.0005836941,0.0003724937,0.00004295897,0.0003179815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009194112,0.00007851839,0.000008789027,0.039718,0.0002066725,0.000002874202,0.0001035527,0.000001800053,0.00009927007,0.0001098378,0.005271589,0.9543899],"study_design_scores_gemma":[0.0003530947,0.000004071122,0.00000264428,0.02140086,0.0008271433,0.000008237094,0.000006892838,0.00005316833,0.0006420197,0.00004301997,0.9759318,0.000727096],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003630756,0.9912784,0.00001338928,0.00003214219,0.001508928,0.0004943964,0.006164694,0.00006140528,0.0004103088],"genre_scores_gemma":[0.0001327183,0.9957748,0.00004944404,0.0000127763,0.001394592,0.001098586,0.0001271878,0.0001446836,0.001265185],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9706602,"threshold_uncertainty_score":0.9996268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2922582842","doi":"10.2174/1568009619666190326120833","title":"Inhibition of PI3K/mTOR Pathways with GDC-0980 in Pediatric Leukemia: Impact on Abnormal FLT-3 Activity and Cooperation with Intracellular Signaling Targets","year":2019,"lang":"en","type":"article","venue":"Current Cancer Drug Targets","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Leukemia; Phosphorylation; Pharmacology; Kinase; IC50; Cancer research; Chemistry; Apoptosis; Medicine; In vitro; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.008210147615025337,"gpt":0.2438397091180066,"spread":0.2356295615029813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002703697,0.0003537703,0.0003505178,0.0001364898,0.00006506102,0.00003050504,0.0001174029,0.00014361,0.00005449748],"category_scores_gemma":[0.0000179507,0.0002768101,0.00006364526,0.0002349136,0.00007778221,0.00004112563,0.00005814016,0.0003356412,0.000004315196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002781543,"about_ca_system_score_gemma":0.000600901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001549921,"about_ca_topic_score_gemma":0.0001703823,"domain_scores_codex":[0.9982935,0.00009971584,0.0002842929,0.0006123906,0.0003087231,0.0004014244],"domain_scores_gemma":[0.9990945,0.00002918444,0.0002762357,0.0002944259,0.000184606,0.0001210051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001887493,0.0002278103,0.1093499,0.000392015,0.00007339587,0.000009245427,0.0004539098,0.03522548,0.8482951,0.00001758618,0.0003507742,0.003717315],"study_design_scores_gemma":[0.002688359,0.001239174,0.01914451,0.0003068108,0.00006387129,0.000006270041,0.00004235834,0.001384489,0.9742278,0.00001074419,0.0003462427,0.000539399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990449,0.007826734,0.0006187933,0.00002793867,0.0003288903,0.0005611595,0.0001081568,0.00001772109,0.00006160541],"genre_scores_gemma":[0.9980866,0.001033195,0.0001222496,0.00002777282,0.0004090473,0.0000871291,0.0001638109,0.00004768167,0.00002247015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1259327,"threshold_uncertainty_score":0.9999684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2987452154","doi":"10.2174/1568009619666191111153049","title":"In Vitro Investigation Demonstrates IGFR/VEGFR Receptor Cross Talk and Potential of Combined Inhibition in Pediatric Central Nervous System Atypical Teratoid Rhabdoid Tumors","year":2019,"lang":"en","type":"article","venue":"Current Cancer Drug Targets","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Receptor tyrosine kinase; Insulin-like growth factor 1 receptor; Cancer research; Biology; Receptor; Growth factor receptor; Growth factor; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.005075892739689982,"gpt":0.2363576026332252,"spread":0.2312817098935352,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001376078,0.0001720084,0.0002322754,0.00008053245,0.00003016257,0.00002465281,0.00006787928,0.0001042087,0.00001084619],"category_scores_gemma":[0.00001254385,0.0001740505,0.00005797597,0.000144772,0.00006942402,0.00001841022,0.00005644922,0.0001522197,0.000002351162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009744832,"about_ca_system_score_gemma":0.0001732177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001129562,"about_ca_topic_score_gemma":0.00004641682,"domain_scores_codex":[0.9987096,0.00007910492,0.0004109404,0.000371124,0.0001477543,0.0002815296],"domain_scores_gemma":[0.9995438,0.000007363567,0.0001621716,0.0001360932,0.0000692194,0.00008135944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006123783,0.0001074464,0.1721413,0.0008646672,0.00001205156,0.000005039361,0.000227401,0.00279434,0.8208115,0.00001290597,0.000319291,0.002091703],"study_design_scores_gemma":[0.003414023,0.000117831,0.1380691,0.0004869878,0.0000265574,0.00001336929,0.0001656063,0.006761692,0.850299,0.00005881783,0.0001382699,0.0004487619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926326,0.005996715,0.00004134755,0.00005862251,0.0008648919,0.0003098003,0.00007279444,0.00001159865,0.00001167476],"genre_scores_gemma":[0.9986041,0.000652336,0.00009065757,0.00002442836,0.0003137655,0.00004282084,0.0002365614,0.00001730172,0.00001805151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03407224,"threshold_uncertainty_score":0.7097573,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}